Cohance Lifesciences Limited — Investor Meet, 07-12-2024: Analysts/Institutional Investor Meet/Con. Call Updates

Suven Pharmaceuticals Limited will conduct a conference call for investors to discuss its acquisition of NJ Bio. The management team, including key executives, will lead the session, which will start with a brief overview before opening the floor for Q&A. This call presents an opportunity for stakeholders to gain insights into the strategic implications of the acquisition and how it fits within the company's growth trajectory.

Details for joining the call have been shared, including dial-in numbers for various regions, emphasizing the importance of pre-registration to facilitate participation.